Birgit Knoechel, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2022 | 407 | 1.700 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2022 | 651 | 0.880 |
Why?
|
| Autoantigens | 7 | 2013 | 892 | 0.640 |
Why?
|
| Galectins | 1 | 2021 | 269 | 0.640 |
Why?
|
| Immune Evasion | 1 | 2021 | 360 | 0.610 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2021 | 5170 | 0.580 |
Why?
|
| Lymphoma, B-Cell | 1 | 2022 | 931 | 0.530 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2014 | 584 | 0.450 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1520 | 0.450 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 1376 | 0.440 |
Why?
|
| Autoimmunity | 6 | 2007 | 1349 | 0.430 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 2177 | 0.420 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2009 | 2988 | 0.410 |
Why?
|
| Receptors, Notch | 2 | 2015 | 739 | 0.400 |
Why?
|
| Interleukin-2 | 4 | 2007 | 1904 | 0.390 |
Why?
|
| Multiple Myeloma | 8 | 2022 | 5185 | 0.390 |
Why?
|
| T-Lymphocytes | 9 | 2022 | 10179 | 0.360 |
Why?
|
| Carcinoma, Adenoid Cystic | 3 | 2018 | 252 | 0.350 |
Why?
|
| Clonal Anergy | 2 | 2008 | 169 | 0.340 |
Why?
|
| Immune Tolerance | 6 | 2013 | 2258 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2018 | 78 | 0.310 |
Why?
|
| Receptor, Notch1 | 3 | 2014 | 502 | 0.290 |
Why?
|
| B-Lymphocytes | 2 | 2013 | 4665 | 0.280 |
Why?
|
| Leukemia | 1 | 2013 | 1509 | 0.250 |
Why?
|
| Autoimmune Diseases | 2 | 2013 | 2134 | 0.230 |
Why?
|
| Chromatin | 2 | 2016 | 2931 | 0.220 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3794 | 0.220 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2022 | 37 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2022 | 1581 | 0.210 |
Why?
|
| Genetic Heterogeneity | 2 | 2016 | 733 | 0.200 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 5854 | 0.200 |
Why?
|
| Lymphocyte Activation | 7 | 2013 | 5524 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2022 | 2540 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2022 | 318 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3645 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2016 | 1344 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2007 | 4386 | 0.180 |
Why?
|
| Antigens, CD19 | 1 | 2022 | 380 | 0.180 |
Why?
|
| Germinal Center | 1 | 2022 | 377 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3547 | 0.170 |
Why?
|
| Blastomeres | 1 | 2018 | 28 | 0.170 |
Why?
|
| Leukemia, Myeloid | 1 | 2022 | 707 | 0.160 |
Why?
|
| Peptidomimetics | 1 | 2018 | 34 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2022 | 671 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 8 | 2008 | 6380 | 0.150 |
Why?
|
| Clonal Deletion | 2 | 2008 | 79 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 4 | 2006 | 573 | 0.150 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2018 | 147 | 0.150 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 16674 | 0.140 |
Why?
|
| Neoplasm, Residual | 2 | 2020 | 973 | 0.140 |
Why?
|
| Apoptosis | 5 | 2018 | 9718 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 727 | 0.140 |
Why?
|
| Mice, Transgenic | 8 | 2008 | 9731 | 0.140 |
Why?
|
| Genes, myc | 2 | 2014 | 399 | 0.140 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.140 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 179 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2018 | 5973 | 0.130 |
Why?
|
| Transcription Factors | 3 | 2016 | 12209 | 0.130 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 135 | 0.130 |
Why?
|
| Tretinoin | 1 | 2018 | 517 | 0.130 |
Why?
|
| Cell Differentiation | 5 | 2009 | 11478 | 0.130 |
Why?
|
| Ovalbumin | 6 | 2008 | 719 | 0.130 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2018 | 298 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2014 | 893 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 105 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3706 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 8430 | 0.120 |
Why?
|
| Mutation | 8 | 2021 | 29777 | 0.120 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 1271 | 0.120 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7719 | 0.110 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2014 | 216 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6311 | 0.110 |
Why?
|
| Adoptive Transfer | 5 | 2008 | 844 | 0.110 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1420 | 0.110 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1005 | 0.100 |
Why?
|
| Coculture Techniques | 2 | 2006 | 1342 | 0.100 |
Why?
|
| Azepines | 1 | 2014 | 334 | 0.100 |
Why?
|
| Mice | 16 | 2022 | 81154 | 0.100 |
Why?
|
| Glycolysis | 1 | 2015 | 830 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1783 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2020 | 3591 | 0.100 |
Why?
|
| Signal Transduction | 6 | 2015 | 23398 | 0.100 |
Why?
|
| Animals | 21 | 2022 | 168660 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2022 | 3024 | 0.090 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 792 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 634 | 0.090 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 933 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 3389 | 0.080 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 13691 | 0.080 |
Why?
|
| Triazoles | 1 | 2014 | 904 | 0.080 |
Why?
|
| Inflammation | 2 | 2007 | 10629 | 0.080 |
Why?
|
| Lymphocyte Subsets | 1 | 2009 | 315 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3874 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2008 | 1837 | 0.080 |
Why?
|
| Humans | 29 | 2023 | 743811 | 0.070 |
Why?
|
| Zebrafish | 1 | 2018 | 2995 | 0.070 |
Why?
|
| Histones | 2 | 2014 | 2598 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 29052 | 0.070 |
Why?
|
| Genome, Human | 1 | 2020 | 4418 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2016 | 2951 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4437 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 3463 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2009 | 985 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1999 | 906 | 0.070 |
Why?
|
| Indoles | 1 | 2014 | 1841 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2008 | 14563 | 0.060 |
Why?
|
| Plasma Cells | 2 | 2020 | 593 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2006 | 454 | 0.060 |
Why?
|
| Lymphopenia | 1 | 2007 | 285 | 0.060 |
Why?
|
| Interleukin-17 | 2 | 2009 | 902 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2009 | 1057 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2022 | 2718 | 0.060 |
Why?
|
| Eosinophils | 2 | 1999 | 954 | 0.060 |
Why?
|
| Melanoma | 1 | 2021 | 5508 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2022 | 19232 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2005 | 527 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2529 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39001 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3524 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 1377 | 0.050 |
Why?
|
| Antigens, CD | 4 | 2005 | 4026 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1876 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 9440 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2022 | 471 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2021 | 2039 | 0.050 |
Why?
|
| Models, Animal | 1 | 2007 | 2172 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2022 | 430 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2021 | 2506 | 0.040 |
Why?
|
| Cytokines | 2 | 2023 | 7324 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 1115 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 1608 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 4803 | 0.040 |
Why?
|
| Bronchial Provocation Tests | 1 | 1999 | 227 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 35122 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 999 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 40964 | 0.040 |
Why?
|
| U937 Cells | 1 | 2018 | 268 | 0.040 |
Why?
|
| Kinetics | 1 | 2005 | 6476 | 0.040 |
Why?
|
| Genomics | 1 | 2013 | 5714 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2018 | 365 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2020 | 508 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2014 | 4009 | 0.030 |
Why?
|
| Female | 10 | 2022 | 380020 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2003 | 901 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2022 | 2617 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4183 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 409 | 0.030 |
Why?
|
| Base Sequence | 3 | 2014 | 12798 | 0.030 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 21 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56392 | 0.030 |
Why?
|
| Thiadiazoles | 1 | 2014 | 55 | 0.030 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 121 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2131 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 1996 | 389 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2016 | 684 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2014 | 5445 | 0.030 |
Why?
|
| Male | 8 | 2021 | 349776 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2009 | 10477 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 1085 | 0.030 |
Why?
|
| Child | 1 | 2021 | 77637 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 85729 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1707 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2018 | 4221 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1691 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 163178 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 474 | 0.030 |
Why?
|
| Allergens | 1 | 1999 | 1320 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 21824 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 3680 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 2942 | 0.030 |
Why?
|
| Mitochondria | 2 | 2018 | 3513 | 0.020 |
Why?
|
| Antigens, Differentiation | 2 | 2005 | 927 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1434 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1917 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2085 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2014 | 1545 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 213241 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2018 | 3000 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2014 | 2256 | 0.020 |
Why?
|
| Interleukin-4 | 2 | 2006 | 1147 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 936 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2944 | 0.020 |
Why?
|
| Cell Survival | 3 | 2008 | 5881 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2014 | 1252 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 1179 | 0.020 |
Why?
|
| Binding Sites | 1 | 2018 | 6111 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2009 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2022 | 4286 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2020 | 7880 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8337 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 213889 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 6170 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 1088 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5179 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 864 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 2438 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5532 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 18107 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2712 | 0.020 |
Why?
|
| Lectins, C-Type | 2 | 1999 | 589 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 471 | 0.010 |
Why?
|
| Mitomycin | 1 | 2004 | 259 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
| Alopecia | 1 | 2006 | 382 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1157 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9377 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18027 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 12944 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3492 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2006 | 1266 | 0.010 |
Why?
|
| Lung | 1 | 1999 | 9858 | 0.010 |
Why?
|
| Asthma | 1 | 1999 | 6010 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21733 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 2008 | 0.010 |
Why?
|
| Immunization | 1 | 2004 | 1255 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11360 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1999 | 273 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 1350 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 3205 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 12066 | 0.010 |
Why?
|
| Histamine | 1 | 1999 | 507 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1347 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1999 | 768 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1999 | 625 | 0.010 |
Why?
|
| Saponins | 1 | 1996 | 50 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4568 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57744 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4670 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1999 | 902 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12259 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 4552 | 0.010 |
Why?
|
| Interleukins | 1 | 1999 | 791 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2006 | 2958 | 0.010 |
Why?
|
| Skin | 1 | 2006 | 4372 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5096 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9648 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 63042 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 4422 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10940 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1996 | 13028 | 0.000 |
Why?
|